675 related articles for article (PubMed ID: 18808729)
1. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.
Mackle T; Gendy SS; Walsh M; McConn-Walsh R; Costello RW; Walsh MT
J Laryngol Otol; 2008 Dec; 122(12):1309-17. PubMed ID: 18808729
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
3. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis.
Wilson AM; Duong M; Crawford L; Denburg J
Clin Exp Allergy; 2005 Jan; 35(1):39-44. PubMed ID: 15649264
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
6. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
[TBL] [Abstract][Full Text] [Related]
7. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids.
Wright ED; Christodoulopoulos P; Small P; Frenkiel S; Hamid Q
Laryngoscope; 1999 Apr; 109(4):551-6. PubMed ID: 10201739
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
[TBL] [Abstract][Full Text] [Related]
9. Nasal epithelial cells express IL-10 at levels that negatively correlate with clinical symptoms in patients with house dust mite allergy.
Muller B; de Groot EJ; Kortekaas IJ; Fokkens WJ; van Drunen CM
Allergy; 2007 Sep; 62(9):1014-22. PubMed ID: 17686104
[TBL] [Abstract][Full Text] [Related]
10. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge.
Semik-Orzech A; Barczyk A; Wiaderkiewicz R; Pierzchala W
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):418-24. PubMed ID: 19927541
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
[TBL] [Abstract][Full Text] [Related]
14. Nasal endothelial interleukin-10 expression is negatively correlated with nasal symptoms after allergen provocation.
Muller B; de Groot EJ; Kortekaas IJ; Fokkens WJ; van Drunen CM
Allergy; 2009 May; 64(5):738-45. PubMed ID: 19383027
[TBL] [Abstract][Full Text] [Related]
15. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis.
Fransson M; Adner M; Erjefält J; Jansson L; Uddman R; Cardell LO
Respir Res; 2005 Sep; 6(1):100. PubMed ID: 16146574
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranasal azelastine on the response to nasal allergen challenge.
Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
[TBL] [Abstract][Full Text] [Related]
18. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
Boot JD; de Kam ML; Mascelli MA; Miller B; van Wijk RG; de Groot H; Cohen AF; Diamant Z
Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluticasone on neuropeptides in nasal lavage in persistent allergic rhinitis.
Schäper C; Gustavus B; Koch B; Ewert R; Felix SB; Kunkel G; Noga O; Gläser S
J Investig Allergol Clin Immunol; 2010; 20(3):214-21. PubMed ID: 20635787
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of eosinophil cationic protein release in mite-allergic rhinitis after specific nasal provocation.
Branco-Ferreira M; Palma-Carlos ML; Santos MC; Lopes AP; Palma-Carlos AG
Allerg Immunol (Paris); 1998 Apr; 30(4):104, 107-11. PubMed ID: 9631691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
